Senior insider sale
EVP R&D, Chief Medical Officer at ALKERMES PLC. — senior position signals high conviction
$1.38M
43.75K shares
HOPKINSON CRAIG C. plans to sell 43.75K shares of ALKERMES PLC. valued at approximately $1.38M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of employee stock options
Broker assisted cashless exercise
Vesting of performance share award
Granted as part of issuer equity compensation plan
Vesting of performance share award
Granted as part of issuer equity compensation plan
Vesting of performance share award
Granted as part of issuer equity compensation plan
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2026 | Exercise of employee stock options Broker assisted cashless exercise | 5K | — |
2/5/2026 | Vesting of performance share award Granted as part of issuer equity compensation plan | 135.00 | — |
3/1/2025 | Vesting of performance share award Granted as part of issuer equity compensation plan | 2.87K | — |
2/26/2025 | Vesting of performance share award Granted as part of issuer equity compensation plan | 1K | — |
| Total | 9K | ||
Completed
Units to sell
9K
Market value
$267.5K
Units to sell
9K
Market value
$305.4K
Units to sell
5K
Market value
$150.0K
Units to sell
4K
Market value
$112.0K
Units to sell
3.75K
Market value
$112.4K
Units to sell
4K
Market value
$117.2K
Planned — Approximate Date
Units to sell
9K
Market value
$319.6K
Units
43.75K
Value
$1.38M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 9K | $267.5K | — | Completed |
2/2/2026 | 9K | $305.4K | — | Completed |
1/8/2026 | 5K | $150.0K | — | Completed |
1/2/2026 | 4K | $112.0K | — | Completed |
12/3/2025 | 3.75K | $112.4K | — | Completed |
12/1/2025 | 4K | $117.2K | — | Completed |
| Planned — Approximate Date | ||||
4/1/2026 | 9K | $319.6K | NASDAQ | Planned |
| Total | 43.75K | $1.38M | ||